Why it was recalled
Mislabeling: preservative free product labeled as preserved.
Product description
ASCORBIC ACID PRESERVED INJECTION SOLUTION, 500 mg/mL, 30 mL Sterile Multiple-Dose Vial, RX ONLY, Compounded by: Empower Pharmacy, 5980 W Sam Houston Pkwy N Ste 300 Houston, TX 77041, NDC 72627-2405-1
Lot numbers, UPCs & expiration codes
Lot: 606775 BUD: 09/25/2023
Where it was sold
Distributed Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0865-2023
- Classification
- Class II
- Status
- Completed
- Recall initiated
- May 12, 2023
- FDA report date
- Jun 14, 2023
- Quantity
- 504 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Empower Clinic Services LLC dba Empower Pharmacy
Original FDA data
Every field from FDA enforcement report D-0865-2023, exactly as published.
Show all FDA fields
- City
- Houston
- State
- TX
- Status
- Completed
- Country
- United States
- Event ID
- 92367
- Address
- 5980 W Sam Houston Pkwy N Ste 300
- Code information
- Lot: 606775 BUD: 09/25/2023
- Postal code
- 77041-5251
- Report date
- Jun 14, 2023
- Product type
- Drugs
- Recall number
- D-0865-2023
- Classification
- Class II
- Recalling firm
- Empower Clinic Services LLC dba Empower Pharmacy
- Product quantity
- 504 vials
- Reason for recall
- Mislabeling: preservative free product labeled as preserved.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- ASCORBIC ACID PRESERVED INJECTION SOLUTION, 500 mg/mL, 30 mL Sterile Multiple-Dose Vial, RX ONLY, Compounded by: Empower Pharmacy, 5980 W Sam Houston Pkwy N Ste 300 Houston, TX 77041, NDC 72627-2405-1
- Distribution pattern
- Distributed Nationwide in the USA
- Recall initiation date
- May 12, 2023
- Initial firm notification
- Center classification date
- Jun 5, 2023